ChemPartner Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
2,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
5
ChemPartner General Information
Description
Provider of a drug discovery and development service intended to offer high-quality and cost-effective services to the biopharmaceutical industry. The company offers a broad range of integrated services across the drug discovery and development process, enabling it to serve the pharmaceutical and biotechnology companies around the globe.
Contact Information
Website
www.chempartner.com(Operating Subsidiary)
Corporate Office
- Room 301
- No. 965, Halley Road
- Shanghai, 201203
- China
Corporate Office
- Room 301
- No. 965, Halley Road
- Shanghai, 201203
- China
ChemPartner Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ChemPartner Comparisons
Industry
Financing
Details
ChemPartner Competitors (57)
One of ChemPartner’s 57 competitors is Pharmaron, a Formerly VC-backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pharmaron | Formerly VC-backed | Beijing, China | ||||
| Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
| Latitude Pharmaceuticals | Private Debt Financed | San Diego, CA | ||||
| Aragen Life Sciences | Private Equity-Backed | Hyderabad, India | ||||
| WuXi Chemistry | Corporation | Shanghai, China |
ChemPartner Patents
ChemPartner Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026194946-A1 | Camptothecin compound and use thereof | Pending | 18-Mar-2025 | ||
| WO-2026158702-A1 | Anti-tumor drug, pharmaceutical composition, and use thereof | Pending | 27-Jan-2025 | ||
| WO-2026098695-A1 | Antibody labeling method | Pending | 08-Nov-2024 | ||
| AU-2020401188-A1 | Alpha-5 beta-1 inhibitors | Active | 10-Dec-2019 | ||
| AU-2020401188-B2 | Alpha-5 beta-1 inhibitors | Active | 10-Dec-2019 | C07C279/18 |
ChemPartner Signals
ChemPartner Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ChemPartner Investments (5)
ChemPartner’s most recent deal was a Later Stage VC with Circle Pharma for . The deal was made on 02-Dec-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Circle Pharma | 02-Dec-2018 | Later Stage VC | Drug Discovery | ||
| Circle Pharma | 25-Apr-2017 | Later Stage VC | Drug Discovery | ||
| Boteng Zhituo Pharmaceutical | 08-Sep-2016 | Corporate | Pharmaceuticals | ||
| Morphic Therapeutic | 30-Jun-2016 | Early Stage VC | Drug Discovery | ||
| Morphic Therapeutic | 01-Jun-2015 | Seed Round | Drug Discovery |
ChemPartner Exits (3)
ChemPartner’s most recent exit was on 08-Sep-2016 from Boteng Zhituo Pharmaceutical. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Boteng Zhituo Pharmaceutical | 08-Sep-2016 | Completed |
|
||
| Morphic Therapeutic | 30-Jun-2016 | Completed |
|
||
| Morphic Therapeutic | 01-Jun-2015 | Seed Round | Completed |
|
ChemPartner FAQs
-
When was ChemPartner founded?
ChemPartner was founded in 2003.
-
Where is ChemPartner headquartered?
ChemPartner is headquartered in Shanghai, China.
-
What is the size of ChemPartner?
ChemPartner has 2,000 total employees.
-
What industry is ChemPartner in?
ChemPartner’s primary industry is Drug Discovery.
-
Is ChemPartner a private or public company?
ChemPartner is a Private company.
-
What is the current valuation of ChemPartner?
The current valuation of ChemPartner is .
-
What is ChemPartner’s current revenue?
The current revenue for ChemPartner is .
-
How much funding has ChemPartner raised over time?
ChemPartner has raised $117M.
-
Who are ChemPartner’s investors?
MAGS Capital and TPG have invested in ChemPartner.
-
Who are ChemPartner’s competitors?
Pharmaron, Dalton Pharma Services, Latitude Pharmaceuticals, Aragen Life Sciences, and WuXi Chemistry are some of the 57 competitors of ChemPartner.
-
When was ChemPartner acquired?
ChemPartner was acquired on 16-Aug-2018.
-
Who acquired ChemPartner?
ChemPartner was acquired by Chempartner Pharmatech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process